ClinVar Miner

Submissions for variant NM_014363.6(SACS):c.10907G>A (p.Arg3636Gln)

gnomAD frequency: 0.00001  dbSNP: rs281865119
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000032007 SCV000798075 uncertain significance Charlevoix-Saguenay spastic ataxia 2018-02-22 criteria provided, single submitter clinical testing
Invitae RCV001244900 SCV001418153 uncertain significance Spastic paraplegia 2021-08-12 criteria provided, single submitter clinical testing This sequence change replaces arginine with glutamine at codon 3636 of the SACS protein (p.Arg3636Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs281865119, ExAC 0.002%). This missense change has been observed in individual(s) with clinical features of autosomal recessive spastic ataxia of Charlevoix-Saguenay in which this allele occurred in the homozygous state or in trans with an additional SACS variant on the opposite allele (PMID: 20876471). ClinVar contains an entry for this variant (Variation ID: 38457). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Genome-Nilou Lab RCV000032007 SCV002026488 uncertain significance Charlevoix-Saguenay spastic ataxia 2021-09-05 criteria provided, single submitter clinical testing
GeneReviews RCV000032007 SCV000054716 not provided Charlevoix-Saguenay spastic ataxia no assertion provided literature only
Natera, Inc. RCV000032007 SCV002086166 uncertain significance Charlevoix-Saguenay spastic ataxia 2021-01-13 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.